Xtant Medical (NYSEAMERICAN:XTNT) Shares Cross Above 200-Day Moving Average - Here's What Happened

Key Points

• Xtant Medical Holdings, Inc. shares crossed above their 200-day moving average of $0.58, trading as high as $0.65 on Tuesday.
• The company has seen significant institutional activity, with Nantahala Capital Management increasing its holdings by 500.3% in the second quarter.
• Xtant Medical specializes in regenerative medicine products and medical devices for orthopedic and neurological applications.

Shares of Xtant Medical Holdings, Inc. (NYSEAMERICAN:XTNT - ) crossed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $0.58 and traded as high as $0.65. Xtant Medical shares last traded at $0.65, with a volume of 38,774 shares trading hands.

Xtant Medical Stock Down 0.2%

The company has a market capitalization of $90.86 million, a PE ratio of -16.23 and a beta of -0.15. The company has a debt-to-equity ratio of 0.46, a quick ratio of 1.16 and a current ratio of 2.47. The stock's 50 day moving average is $0.62 and its 200 day moving average is $0.58.

Institutional Inflows and Outflows

Several institutional investors have recently made changes to their positions in XTNT. Nantahala Capital Management LLC increased its holdings in shares of Xtant Medical by 500.3% in the second quarter. Nantahala Capital Management LLC now owns 68,394,000 shares of the medical device company's stock worth $50,543,000 after purchasing an additional 57,000,000 shares during the period. AWM Investment Company Inc. bought a new position in shares of Xtant Medical in the second quarter worth $4,875,000. Crescent Grove Advisors LLC increased its holdings in shares of Xtant Medical by 94.3% in the second quarter. Crescent Grove Advisors LLC now owns 412,024 shares of the medical device company's stock worth $304,000 after purchasing an additional 200,000 shares during the period. Mink Brook Asset Management LLC increased its holdings in shares of Xtant Medical by 125.8% in the second quarter. Mink Brook Asset Management LLC now owns 109,466 shares of the medical device company's stock worth $81,000 after purchasing an additional 60,997 shares during the period. Finally, Jane Street Group LLC bought a new position in shares of Xtant Medical in the second quarter worth $26,000. Institutional investors own 69.33% of the company's stock.

Xtant Medical Company Profile

Xtant Medical Holdings, Inc provides regenerative medicine products and medical devices for orthopedic and neurological surgeons. It offers OsteoSponge that provides a natural scaffold for cellular in-growth and exposes bone-forming proteins to the healing environment; OsteoSelect DBM Putty to mold into any shape and compressed into bony voids; OsteoSelect PLUS DBM Putty to deliver handling properties and ensure patient safety through validated terminal sterilization; 3Demin, a family of allografts that maximizes osteoconductivity and the osteoinductive potential of human bone; OsteoFactor, a processed allograft that contains retained growth factors found within the endosteum layer of allograft bone; OsteoVive Plus, a growth factor enriched cellular bone matrix; and nanOss family of products that provide osteoconductive nano-structured hydroxyapatite and an engineered extracellular matrix bioscaffold collagen carrier.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.